Back
Signature Bank Vs. Aligos Therapeutics Industry Stock Comparison
Sell
37
SBNY
Signature Bank
Last Price:
$1.2500
Seasonality Move:
108.55%
Buy
62
ALGS
Aligos Therapeutics
Last Price:
$39.41
Seasonality Move:
7.18%
Sell
37
Signature Bank (SBNY)
is a Sell
Is Signature Bank a Buy, Sell or Hold?
-
The current Signature Bank [SBNY] share price is $1.2500. The Score for SBNY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
SBNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $38.35. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SBNY Stock Price Chart
What is Signature Bank's stock price today?
-
The Signature Bank share price today is $1.2500Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SBNY is experiencing slight selling pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $38.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
SBNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 40.72 | Sell |
Chaikin Money Flow: | -41742 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.2166 - 1.5566) | Sell |
Bollinger Bands (100): | (1.4113 - 2.0513) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.1 | Buy |
Relative Strength Index (14 RSI): | 79.33 | Buy |
Chaikin Money Flow: | 265554 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.3 - 32.5) | Buy |
Bollinger Bands (100): | (7.16 - 22.66) | Buy |
SBNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.4 | Sell |
20-day SMA: | 1.41 | Sell |
50-day SMA: | 1.46 | Sell |
200-day SMA: | 2.19 | Sell |
8-day EMA: | 1.37 | Sell |
20-day EMA: | 1.41 | Sell |
50-day EMA: | 1.51 | Sell |
200-day EMA: | 3.64 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34 | Buy |
20-day SMA: | 28.23 | Buy |
50-day SMA: | 17.95 | Buy |
200-day SMA: | 16.14 | Buy |
8-day EMA: | 33.62 | Buy |
20-day EMA: | 28.8 | Buy |
50-day EMA: | 21.66 | Buy |
200-day EMA: | 17.2 | Buy |
Signature Bank Earnings Growth & SBNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.27 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Signature Bank Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |